Back
Virtus AllianzGI Diversified Income & Convertible Fund Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
63
ACV
Virtus AllianzGI Diversified Income & Convertible Fund
Last Price:
$22.14
Seasonality Move:
5.82%
Sell
43
ASND
Ascendis Pharma AS
Last Price:
$171.05
Seasonality Move:
10.84%
Buy
63
Virtus AllianzGI Diversified Income & Convertible Fund (ACV)
is a Buy
Is Virtus AllianzGI Diversified Income & Convertible Fund a Buy, Sell or Hold?
-
The current Virtus AllianzGI Diversified Income & Convertible Fund [ACV] share price is $22.31. The Score for ACV is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
ACV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $171.72. The Score for ASND is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACV Stock Price Chart
What is Virtus AllianzGI Diversified Income & Convertible Fund's stock price today?
-
The Virtus AllianzGI Diversified Income & Convertible Fund share price today is $22.31The current trend is moderately bullish and ACV is experiencing selling pressure, which indicates risk of future bearish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $171.72The current trend is moderately bullish and ASND is experiencing slight selling pressure.
ACV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 67.15 | Buy |
Chaikin Money Flow: | -20106 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.42 - 22.28) | Buy |
Bollinger Bands (100): | (19.82 - 22.56) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.86 | Buy |
Relative Strength Index (14 RSI): | 57.7 | Buy |
Chaikin Money Flow: | -92140 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (156.43 - 171.29) | Buy |
Bollinger Bands (100): | (137 - 167.2) | Buy |
ACV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.31 | Sell |
20-day SMA: | 22.01 | Buy |
50-day SMA: | 20.64 | Buy |
200-day SMA: | 21.45 | Buy |
8-day EMA: | 22.3 | Buy |
20-day EMA: | 21.93 | Buy |
50-day EMA: | 21.32 | Buy |
200-day EMA: | 21.3 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 173.95 | Sell |
20-day SMA: | 165.45 | Buy |
50-day SMA: | 160.26 | Buy |
200-day SMA: | 142.6 | Buy |
8-day EMA: | 171.59 | Buy |
20-day EMA: | 167.63 | Buy |
50-day EMA: | 161.82 | Buy |
200-day EMA: | 146.66 | Buy |
Virtus AllianzGI Diversified Income & Convertible Fund Earnings Growth & ACV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.60 per share, an increase this year of $2.06 per share, and an increase next year of $7.40 per share.
Virtus AllianzGI Diversified Income & Convertible Fund Technical Analysis
May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |